Skip to main content Back to Top
Advertisement

COVID-19: Clinician Perspectives on Crisis Management and ICU Creations at your Institution

 

Subscribe on iTune PodcastsListen on Google PlaySubscribe to Stitcher Podcasts Listen on Spotify Subscribe to TuneIn PodcastsSubscribe to iHeartRadio

ASHP sits down with Dr. Jawad Saleh, B.S., PharmD, BCPS, BCCCP, Clinical Manager of Pharmacy Services and Dr. Lucas T. Schulz, PharmD, BCIDP, Clinical Coordinator – Infectious Diseases and Critical Care Pharmacist as they discuss ICU creations in their institution, medication management and workflow modifications in this patient population as well as the transformations, highlights and pharmacy survival in amidst COVID-19.

SPEAKERS

Jawad SalehDr. Jawad Saleh, B.S., PharmD, BCPS, BCCCP is a registered pharmacist who is board-certified in Pharmacotherapy and critical care.

He currently serves as Manager of Clinical Services, Critical Care Coordinator and Affiliate Professor for the Pharmacy Department at The Hospital for Special Surgery.

Dr. Saleh received his Bachelors of Science in Pharmacy and his non- traditional post Doctor of Pharmacy degree from St. John’s University in Queens, New York.

Dr. Saleh created and implemented the first pharmacy clinical program at The Hospital for Special Surgery. He has authored and co-authored publications and presentations regarding perioperative impacts of anesthesia in patients. He is a co-chair for the Pharmacy and Therapeutics, Antimicrobial Stewardship, and sits on the opioid task force. He also serves as a member for several other committees within The Hospital for Surgery.

Lucas SchulzDr. Lucas Schulz is the clinical coordinator for infectious diseases and PGY2 Infectious Diseases residency program director at University of Wisconsin Health. Following graduation from the University of Wisconsin - School of Pharmacy, he completed PGY1 and PGY2 critical care residencies at the University of Wisconsin Hospitals and Clinics. In his current role, he is responsible for all anti-infective use across the UW Health enterprise leading the antimicrobial stewardship program at UW Health and is involved with all institutional committees pertaining to infectious diseases. He has served as PGY2 Infectious Diseases Residency Program Director for 8 years. He is active in ASHP, SIDP, Vizient, and across the state of Wisconsin through the Pharmacy Society of Wisconsin.

Vicki BasalygaVicki Basalyga, Pharm.D., BCPS, BCPPS, is the Director for the Section of Clinical Specialists and Scientists. In this role Vicki serves as an information resource and provides guidance to ASHP members regarding science and scientific developments affecting pharmacy practice in health systems. She serves as secretary to the Section executive committee and coordinates activities to accomplish the objectives established by the Section. Additionally, Vicki has assumed the position of Council Secretary for the ASHP's Council on Therapeutics.

Vicki received her Doctor of Pharmacy from Duquesne University and completed an ASHP accredited PGY1 at Children’s National Medical Center in Washington, DC. Vicki is also a Board Certified Pharmacotherapy Specialist and a Board Certified Pediatric Pharmacotherapy Specialist.

Prior to her current position at ASHP, Vicki practiced as critical care pharmacist in both the Cardiac Intensive Care Unit and the Pediatric Intensive Care Unit at Children’s National Medical Center in Washington, DC. Other activities Vicki performed included drafting policies and procedures, co-chairing the Antimicrobial Stewardship Program, creating and drafting order sets for CPOE conversion and precepting residents and students.



The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.